Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Abbott Laboratories    ABT   US0028241000

Real-time Quote. Real-time BATS US - 05/24 04:59:54 pm
37.715 USD   +0.63%
2d ago Valeant near deal to acquire Bausch & Lomb
2d agoDJBausch & Lomb Nears $9 Billion Sale to Valeant
3d agoDJRoyalty Pharma Lowers Acceptance Threshold For Elan Offer
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisionsForum 
Income Statement Evolution
Abbott Laboratories : Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201020112012201320142015
Sales35 16738 85139 87422 46023 79025 277
Operating income (EBITDA)10 67911 21612 6165 4275 7616 268
Operating profit (EBIT)8 0559 0109 8334 1144 5644 955
Pre-Tax Profit (EBT)-5 1996 263---
Net income4 6264 7295 9632 5402 9333 402
EPS ( $)2,963,013,721,541,892,03
Dividend per Share ( $)1,721,881,670,550,610,63
Yield4,56%4,98%4,42%1,45%1,62%1,67%
Announcement Date01/26/2011
12:44pm		01/25/2012
12:46pm		01/23/2013
12:47pm		---
Finances - Leverage
Abbott Laboratories : Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201020112012201320142015
Debt15 2708 6029 674---
Finance---3 9266 0859 510
Operating income (EBITDA)10 67911 21612 6165 4275 7616 268
Leverage
(Debt/EBITDA)		1,43x0,77x0,77x---
Capital Expenditure1 0151 4921 7951 2821 3061 336
Book Value Per Share (BVPS)14,5 $15,6 $17,0 $15,4 $16,3 $18,4 $
Cash Flow per Share5,61 $5,72 $5,85 $2,25 $2,58 $3,25 $
Announcement Date01/26/2011
12:44pm		01/25/2012
12:46pm		01/23/2013
12:47pm		---
Balance Sheet Analysis
Abbott Laboratories : Balance Sheet Analysis
Assessed data source :
© 2013 Thomson Reuters
Advertisement
Financial Ratios

Size 2013e 2014e
Capitalization 58 863 M$ -
Company Value 54 937 M$ 52 778 M$
Valuation 2013e 2014e
PER (Price / EPS) 24,5x 20,0x
Capitalization / Revenue 2,62x 2,47x
EV / Revenue 2,45x 2,22x
EV / EBITDA 10,1x 9,16x
Yield (DPS / Price) 1,45% 1,62%
Profitability 2013e 2014e
Operating Margin (EBIT / Sales) 18,3% 19,2%
operating laverage (Delta EBIT / Delta Sales) -1,33x 1,84x
Net Margin (Net Profit / Revenue) 11,3% 12,3%
ROA (Net Profit / Asset) 8,47% 7,92%
ROE (Net Profit / Equities) 13,6% 12,4%
Rate of Dividend 35,6% 32,5%
Balance Sheet Analysis 2013e 2014e
CAPEX / Sales   5,71% 5,49%
Cash Flow / Sales (Taux d'autofinancement) 15,6% 16,9%
Capital Intensity (Assets / Sales) 1,34x 1,56x
Financial Leverage (Net Debt / EBITDA) -0,72x -1,06x
Price Earning Ratio
Abbott Laboratories : Price Earning Ratio
EPS & Dividend
Abbott Laboratories : EPS Dividend
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Copyright © 2013 Surperformance. All rights reserved.